GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor. (2012)
Attributed to:
A systematic investigation into the pathogenesis and course of Parkinson's syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bmcl.2012.06.104
PubMed Identifier: 22863203
Publication URI: http://europepmc.org/abstract/MED/22863203
Type: Journal Article/Review
Volume: 22
Parent Publication: Bioorganic & medicinal chemistry letters
Issue: 17
ISSN: 0960-894X